Skip to search formSkip to main contentSkip to account menu

Immunomagnetic Column

Known as: Immunomagnetic Selection Column 
A separation column that when placed in proximity to a magnet creates a high gradient magnetic field strong enough to retain cells labeled with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Diethylnitrosamine genotoxicity evaluated in sprague dawley rats using Pig‐a mutation and reticulocyte micronucleus assays
Diethylnitrosamine (DEN) is a genotoxic carcinogen, but in vivo DNA‐damaging activities are not usually evident in hematopoietic… 
2014
2014
In vitro effects of imatinib on CD34+ cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase
Imatinib is a tailored drug for the treatment of chronic myeloid leukemia (CML), and has substantial activity and a favorable… 
2012
2012
In vivo flow cytometric Pig‐a and micronucleus assays: Highly sensitive discrimination of the carcinogen/noncarcinogen pair benzo(a)pyrene and pyrene using acute and repeated‐dose designs
Combining multiple genetic toxicology endpoints into a single in vivo study, and/or integrating one or more genotoxicity assays… 
2012
2012
Combinatorial Effect of Pharmacological Inhibitors of Lsd-1 and DNMT on γ-Globin Synthesis in Cultured Baboon Bone Marrow Erythroid Progenitors
Abstract 249 Increased levels of fetal hemoglobin (HbF) lessen the severity of symptoms and increase the life span of patients… 
2011
2011
Interlaboratory Pig‐a gene mutation assay trial: Studies of 1,3‐propane sultone with immunomagnetic enrichment of mutant erythrocytes
An international collaborative trial was established to systematically investigate the merits and limitations of a rat in vivo… 
2006
2006
Leukemia-SpecificT-Cell Reactivity Induced by Leukemic Dendritic Cells Is Augmented by 4-1 BBTargeting
Purpose: Acute myelogenous leukemia (AML) blasts are able to differentiate into leukemiaderived dendritic cells (AML-DC), thereby… 
2005
2005
Evaluation of Ph+/CD34+ Residual Cells in Chronic Myeloid Leukemia Patients after Long Lasting Treatment with Imatinib Mesylate.
Although the success of imatinib mesylate therapy represents an exciting advance in targeted cancer therapy, it has still to be… 
Highly Cited
2003
Highly Cited
2003
Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Dendritic cells (DC) are professional antigen-presenting cells that are widely used in the experimental immunotherapy of cancer… 
1998
1998
CD19 selection improves the sensitivity of B cell lymphoma detection.
Reinfusion of residual tumor cells into B cell non-Hodgkin's lymphoma (B-NHL) patients during autologous transplantation may be… 
1994
1994
To develop an aerosoling immunomagnetic device for rapid medical diagnosis from clinical samples. Midterm report, 26 July 1993-30 September 1994
A system for immunomagnetic capture, fluorescent staining, purification and diagnosis of at least bacterial (if not viral… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)